Simultaneous multi-court filing and technical disclosure. Bridging the gap between novel mechanistic biology, post-quantum computing, and rigorous constitutional execution.
This portfolio unites a $500,000,000 corporate debt conversion (USEC to Centrus Energy), a documented violation of ADA Title II regarding neurogenetic disabilities, and a suite of patent-pending biotechnologies.
The State of Maryland fully terminated a wrongful prosecution, yet a duplicate derivative file remains open as a ghost record in NCIC/METERS, creating active bench warrants.
Concurrently, administrative delays and the refusal to accommodate cognitive load (via AI prosthetics) have caused measurable biological harm, necessitating the ZINC-MOD and IPC-04 biopharma interventions.
Quantitative analysis of the Bioinorganic Zinc Modulation strategy vs. traditional Genomic Editing, alongside therapeutic synergy models.
Genomic Editing vs. Bioinorganic Zinc Modulation
Anatomical hiding places for latent provirus
EC50 (Potency) vs CC50 (Cytotoxicity)
Immune Activation via Zinc Chelation
Combining LRA, Chelators, and Vaccines for Cumulative Efficacy
Overall assessment of CRISPR/ZFN vs Bioinorganic Strategy
Coordinated legal actions across State, Federal, and International Trade courts.
Omnibus Master Petition for Writ of Mandamus. Directing the $500M USEC debt conversion to M&T Bank.
Establishment of the PSDLEF Purpose Trust. Enforcing ADA cognitive load constraints.
§ 1983 Civil Rights & ADA Title II. Injunctive relief against NCIC ghost warrants.
Tucker Act Complaint. Uncompensated taking of $500M and illegal exaction of liberty.
Interlocutory Appeal. Resolving the Jurisdictional Dead Zone & USPTO patent denials.
Writ of Certiorari. Mandating AI cognitive prosthetics as constitutional ADA accommodations.
All disclosed subject matter is irrevocably dedicated to the public domain to prevent proprietary enclosure.